The FLI includes gamma-glutamyl transpeptidase as one of its variables; however, elevation of gamma-glutamyl transpeptidase is generally not significant in patients with AIH, [40] and its levels are not affected by the presence of cirrhosis. This evidence concerns the gene GGTLC1 and Cirrhosis.